Advancing Innovation in Oncology

From identifying key biomarkers to a diverse pipeline of investigational therapies, we aspire to lead advancements in cancer care.

Find out more about which tumor types are being studied in currently enrolling late-stage clinical trials.

Learn more about some of the immune signals and pathways tumors exploit to avoid an immune response.

Discover a broad range of development platforms such as small molecules and bispecific antibodies.